Ajooni Biotech cash flow

·UnclassifiedChart ›
Latest FY26
Cash from operations
−₹5.7cr−₹17.7 cr in FY25
Capital spending
₹18.0cr+503.2% on FY25
Free cash flow
−₹23.8cr−₹20.7 cr in FY25
Cash from financing
₹15.1cr−39.2% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—2.21.10.91.0
—0.00.00.00.5
—0.00.00.0−0.2
—0.00.00.00.0
—0.0−0.00.00.0
Changes in working capital
—−15.5−8.6−8.4−1.1
—−1.6−3.37.6−6.7
—0.0−2.20.0−1.9
—−0.10.00.00.0
—0.10.03.1−2.8
—−0.8−9.80.00.0
—5.41.9−8.53.3
—0.00.30.00.0
—−0.70.0−1.11.1
—0.00.00.00.1
Cash from operating activities
5.45.74.33.01.6
—−10.9−20.6−6.5−6.7
—−5.2−16.3−3.5−5.1
—−1.3−0.9−0.50.0
—−0.7−0.3−0.60.0
—0.00.90.50.4
—−5.7−17.7−4.0−5.6
Cash from investing activities
—18.0−1.00.02.9
—0.02.05.60.0
—1.20.00.00.0
—−0.1−1.60.50.0
—0.00.00.0−1.2
—1.30.90.50.2
—−0.1−15.312.2−12.0
—−15.8−17.17.6−15.8
Cash from financing activities
—0.00.00.07.5
—16.2−0.5−2.9−0.8
—0.4−0.30.1−0.7
—0.70.30.60.5
—0.025.40.014.8
—15.124.8−3.621.7
—−6.4−10.00.10.3
—−6.4−10.00.10.3
———0.40.3
Reference items
7.26.33.72.22.8
3.4%3.4%3.2%2.8%3.7%
−23.8−23.8−20.7−9.6−8.4
—−8.7−21.3−9.7—
−₹1.38−₹1.38−₹1.20−₹0.55−₹0.49
—−1.33×−5.26×−1.83×−4.96×
—0.00.90.50.4
—0.70.30.60.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AJOONI₹2.90

Ajooni Biotech Limited

· Unclassified
₹ CrorePeersTOUCHWOODRKECRAJMETBANKAAAKASHGANGAFORGEGLOBEAGROPHOSMcap ₹50 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation1.00.91.12.2—
+ Finance Costs0.50.00.00.0—
+ Interest Income-0.20.00.00.0—
+ Fair Value (Gains) / Losses0.00.00.00.0—
+ Other Reconciling Items0.00.0-0.00.0—
Changes in Working Capital
+ Inventories-1.1-8.4-8.6-15.5—
+ Trade Receivables — Current-6.77.6-3.3-1.6—
+ Other Financial Assets — Current-1.90.0-2.20.0—
+ Other Financial Assets — Non-current0.00.00.0-0.1—
+ Other Current Assets-2.83.10.00.1—
+ Other Non-current Assets0.00.0-9.8-0.8—
+ Trade Payables — Current3.3-8.51.95.4—
+ Other Financial Liabilities — Current0.00.00.30.0—
+ Other Current Liabilities1.1-1.10.0-0.7—
+ Provisions — Current0.10.00.00.0—
Cash from Operating Activities
Profit Before Tax (per I/S)1.63.04.35.75.4
+ Total Adjustments (incl. Working Capital)-6.7-6.5-20.6-10.9—
Cash from Operations (pre-tax)-5.1-3.5-16.3-5.2—
+ Interest Received — Operating0.0-0.5-0.9-1.3—
+ Interest Paid — Operating0.0-0.6-0.3-0.7—
+ Income Taxes Paid0.40.50.90.0—
Cash from Operating Activities-5.6-4.0-17.7-5.7—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)2.90.0-1.018.0—
+ Acq of Intangible Assets0.05.62.00.0—
+ Disp of Fixed Assets0.00.00.01.2—
+ Disp of Other Long-term Assets0.00.5-1.6-0.1—
+ Disp of Interests in Joint Ventures-1.20.00.00.0—
+ Interest Received — Investing0.20.50.91.3—
+ Other Inflows / (Outflows) — Investing-12.012.2-15.3-0.1—
Cash from Investing Activities-15.87.6-17.1-15.8—
Cash from Financing Activities
+ Proceeds from Issue of Shares7.50.00.00.0—
+ Proceeds from Borrowings-0.8-2.9-0.516.2—
+ Repayment of Borrowings-0.70.1-0.30.4—
+ Interest Paid0.50.60.30.7—
+ Other Inflows / (Outflows) — Financing14.80.025.40.0—
Cash from Financing Activities21.7-3.624.815.1—
Net Changes in Cash (pre-FX)0.30.1-10.0-6.4—
Net Changes in Cash0.30.1-10.0-6.4—
Closing Cash0.30.4———
Reference Items
EBITDA2.82.23.76.37.2
EBITDA Margin %3.712.793.223.433.36
Free Cash Flow (CFO − Capex)-8.4-9.6-20.7-23.8-23.8
Free Cash Flow to Equity—-9.7-21.3-8.7—
Free Cash Flow per Basic Share-0.49-0.55-1.20-1.38-1.38
Cash Flow to Net Income-4.96-1.83-5.26-1.33—
Cash Paid for Taxes0.40.50.90.0—
Cash Paid for Interest0.50.60.30.7—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.